Stay updated on FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Sign up to get notified when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.

Latest updates to the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the completed FORTUNE study comparing two Foster inhalers for controlled asthma is now available, with detailed study information and links to results-related materials, replacing the error page.SummaryDifference95%

- Check14 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition in terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe site's footer revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now displays a 403 Forbidden error, showing an access-denied message instead of the study content.SummaryDifference21%

Stay in the know with updates to FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Enter your email address, and we'll notify you when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.